Disease | ornithine transcarbamylase deficiency |
Comorbidity | C0019204|hepatocellular carcinoma |
Sentences | 2 |
PubMedID- 22546217 | Rharg exhibits significant cytotoxicity against cancer cells such as prostate cancer, melanoma, and hepatocellular carcinoma with oct deficiency. |
PubMedID- 22129577 | A 66 year old woman who is a manifesting heterozygote for ornithine transcarbamylase deficiency (otcd) presented with hepatocellular carcinoma (hcc). |
Page: 1